Antibiotic Resistance Profiling and Phylogenicity of Uropathogenic Bacteria Isolated from Patients with Urinary Tract Infections. 2023

Muhammad Ajmal Khan, and Atta Ur Rahman, and Bakhtawar Khan, and Samiah Hamad Al-Mijalli, and Amal S Alswat, and Aftab Amin, and Refaat A Eid, and Mohamed Samir A Zaki, and Sadia Butt, and Jamshaid Ahmad, and Eman Fayad, and Amin Ullah
Centre for Biotechnology and Microbiology, University of Peshawar, Peshawar 25000, Khyber Pakhtunkhwa, Pakistan.

Urinary tract infections (UTIs) are healthcare problems that commonly involve bacterial and, in some rare instances, fungal or viral infections. The irrational prescription and use of antibiotics in UTI treatment have led to an increase in antibiotic resistance. Urine samples (145) were collected from male and female patients from Lower Dir, Khyber Pakhtunkhwa (KP), Pakistan. Biochemical analyses were carried out to identify uropathogens. Molecular analysis for the identification of 16S ribosomal RNA in samples was performed via Sanger sequencing. Evolutionary linkage was determined using Molecular Evolutionary Genetics Analysis-7 (MEGA-7). The study observed significant growth in 52% of the samples (83/145). Gram-negative bacteria were identified in 85.5% of samples, while Gram-positive bacteria were reported in 14.5%. The UTI prevalence was 67.5% in females and 32.5% in males. The most prevalent uropathogenic bacteria were Klebsiella pneumoniae (39.7%, 33/83), followed by Escherichia coli (27.7%, 23/83), Pseudomonas aeruginosa (10.8%, 9/83), Staphylococcus aureus (9.6%, 8/83), Proteus mirabilis (7.2%, 6/83) and Staphylococcus saprophyticus (4.8%, 4/83). Phylogenetic analysis was performed using the neighbor-joining method, further confirming the relation of the isolates in our study with previously reported uropathogenic isolates. Antibiotic susceptibility tests identified K. pneumonia as being sensitive to imipenem (100%) and fosfomycin (78.7%) and resistant to cefuroxime (100%) and ciprofloxacin (94%). Similarly, E. coli showed high susceptibility to imipenem (100%), fosfomycin (78.2%) and nitrofurantoin (78.2%), and resistance to ciprofloxacin (100%) and cefuroxime (100%). Imipenem was identified as the most effective antibiotic, while cefuroxime and ciprofloxacin were the least. The phylogenetic tree analysis indicated that K. pneumoniae, E. coli, P. aeruginosa, S. aureus and P. mirabilis clustered with each other and the reference sequences, indicating high similarity (based on 16S rRNA sequencing). It can be concluded that genetically varied uropathogenic organisms are commonly present within the KP population. Our findings demonstrate the need to optimize antibiotic use in treating UTIs and the prevention of antibiotic resistance in the KP population.

UI MeSH Term Description Entries

Related Publications

Muhammad Ajmal Khan, and Atta Ur Rahman, and Bakhtawar Khan, and Samiah Hamad Al-Mijalli, and Amal S Alswat, and Aftab Amin, and Refaat A Eid, and Mohamed Samir A Zaki, and Sadia Butt, and Jamshaid Ahmad, and Eman Fayad, and Amin Ullah
January 2017, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences,
Muhammad Ajmal Khan, and Atta Ur Rahman, and Bakhtawar Khan, and Samiah Hamad Al-Mijalli, and Amal S Alswat, and Aftab Amin, and Refaat A Eid, and Mohamed Samir A Zaki, and Sadia Butt, and Jamshaid Ahmad, and Eman Fayad, and Amin Ullah
January 2021, Medeniyet medical journal,
Muhammad Ajmal Khan, and Atta Ur Rahman, and Bakhtawar Khan, and Samiah Hamad Al-Mijalli, and Amal S Alswat, and Aftab Amin, and Refaat A Eid, and Mohamed Samir A Zaki, and Sadia Butt, and Jamshaid Ahmad, and Eman Fayad, and Amin Ullah
January 1988, Mikrobiyoloji bulteni,
Muhammad Ajmal Khan, and Atta Ur Rahman, and Bakhtawar Khan, and Samiah Hamad Al-Mijalli, and Amal S Alswat, and Aftab Amin, and Refaat A Eid, and Mohamed Samir A Zaki, and Sadia Butt, and Jamshaid Ahmad, and Eman Fayad, and Amin Ullah
October 1989, Mikrobiyoloji bulteni,
Muhammad Ajmal Khan, and Atta Ur Rahman, and Bakhtawar Khan, and Samiah Hamad Al-Mijalli, and Amal S Alswat, and Aftab Amin, and Refaat A Eid, and Mohamed Samir A Zaki, and Sadia Butt, and Jamshaid Ahmad, and Eman Fayad, and Amin Ullah
March 1985, Wiadomosci lekarskie (Warsaw, Poland : 1960),
Muhammad Ajmal Khan, and Atta Ur Rahman, and Bakhtawar Khan, and Samiah Hamad Al-Mijalli, and Amal S Alswat, and Aftab Amin, and Refaat A Eid, and Mohamed Samir A Zaki, and Sadia Butt, and Jamshaid Ahmad, and Eman Fayad, and Amin Ullah
November 2009, Epidemiologie, mikrobiologie, imunologie : casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti J.E. Purkyne,
Muhammad Ajmal Khan, and Atta Ur Rahman, and Bakhtawar Khan, and Samiah Hamad Al-Mijalli, and Amal S Alswat, and Aftab Amin, and Refaat A Eid, and Mohamed Samir A Zaki, and Sadia Butt, and Jamshaid Ahmad, and Eman Fayad, and Amin Ullah
January 1998, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie,
Muhammad Ajmal Khan, and Atta Ur Rahman, and Bakhtawar Khan, and Samiah Hamad Al-Mijalli, and Amal S Alswat, and Aftab Amin, and Refaat A Eid, and Mohamed Samir A Zaki, and Sadia Butt, and Jamshaid Ahmad, and Eman Fayad, and Amin Ullah
January 2014, Chemotherapy,
Muhammad Ajmal Khan, and Atta Ur Rahman, and Bakhtawar Khan, and Samiah Hamad Al-Mijalli, and Amal S Alswat, and Aftab Amin, and Refaat A Eid, and Mohamed Samir A Zaki, and Sadia Butt, and Jamshaid Ahmad, and Eman Fayad, and Amin Ullah
January 2023, Pakistan journal of pharmaceutical sciences,
Muhammad Ajmal Khan, and Atta Ur Rahman, and Bakhtawar Khan, and Samiah Hamad Al-Mijalli, and Amal S Alswat, and Aftab Amin, and Refaat A Eid, and Mohamed Samir A Zaki, and Sadia Butt, and Jamshaid Ahmad, and Eman Fayad, and Amin Ullah
January 2002, Therapeutische Umschau. Revue therapeutique,
Copied contents to your clipboard!